EnglishРусский中文EspañolDeutsch
Independent world news

White House pulls Heidi Overton's nomination to lead the FDA

The White House withdrew its nomination of Heidi Overton to head the Food and Drug Administration on Tuesday, a day before a Senate committee vote, after it appeared she lacked the votes to be confirmed.

White House pulls Heidi Overton's nomination to lead the FDA
Photo: CaptJayRuffins / Wikimedia Commons, CC BY-SA 4.0

The administration dropped the nomination of Overton, a physician and White House aide, on November 17, according to Axios, STAT, The Hill and the Guardian. A White House official said it had become clear she did not have the support needed in the Senate.

The Senate Health, Education, Labor and Pensions Committee was due to vote on Wednesday. Republicans hold 12 of its 23 seats, so Overton needed every Republican member to advance. Committee chairman Bill Cassidy said earlier on Tuesday that he remained undecided, according to U.S. media reports.

Several Republican senators had raised concerns about Overton's positions on abortion, vaccines and vaping, the reports said. Overton is an abortion opponent, and Democratic senators had criticised the nomination since it was announced.

President Donald Trump named Overton on August 19 to succeed Marty Makary, who resigned as FDA commissioner in May after 13 months in the post. The agency is currently led by acting commissioner Kyle Diamantas.

The White House has not said who will be nominated next. It previously withdrew the nomination of Casey Means for surgeon general after it became clear she lacked the votes to clear the same committee.

Heidi OvertonFDA commissioner nominationSenate HELP committeeBill CassidyFood and Drug Administration
More in Politics